NO844466L - Fremgangsmaate for fremstilling av pyrimidoisokinolin-derivater - Google Patents

Fremgangsmaate for fremstilling av pyrimidoisokinolin-derivater

Info

Publication number
NO844466L
NO844466L NO844466A NO844466A NO844466L NO 844466 L NO844466 L NO 844466L NO 844466 A NO844466 A NO 844466A NO 844466 A NO844466 A NO 844466A NO 844466 L NO844466 L NO 844466L
Authority
NO
Norway
Prior art keywords
pyrimidoisokinoline
derivatives
preparing
procedure
pyrimidoisokinoline derivatives
Prior art date
Application number
NO844466A
Other languages
English (en)
Other versions
NO162019C (no
NO162019B (no
Inventor
Ikuo Ueda
Youichi Shiokawa
Takashi Manabe
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838331228A external-priority patent/GB8331228D0/en
Priority claimed from GB848405776A external-priority patent/GB8405776D0/en
Priority claimed from GB848425791A external-priority patent/GB8425791D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO844466L publication Critical patent/NO844466L/no
Publication of NO162019B publication Critical patent/NO162019B/no
Publication of NO162019C publication Critical patent/NO162019C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/08—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO844466A 1983-11-23 1984-11-08 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoiskinolinderivater. NO162019C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB838331228A GB8331228D0 (en) 1983-11-23 1983-11-23 Pyrimidoisoquinoline derivatives
GB848405776A GB8405776D0 (en) 1984-03-06 1984-03-06 Pyrimidoisoquinoline derivatives
GB848425791A GB8425791D0 (en) 1984-10-12 1984-10-12 Pyrimidoisoquinoline derivatives

Publications (3)

Publication Number Publication Date
NO844466L true NO844466L (no) 1985-05-24
NO162019B NO162019B (no) 1989-07-17
NO162019C NO162019C (no) 1989-10-25

Family

ID=27262222

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844466A NO162019C (no) 1983-11-23 1984-11-08 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoiskinolinderivater.

Country Status (17)

Country Link
US (1) US4673676A (no)
EP (1) EP0143001B1 (no)
KR (2) KR920008168B1 (no)
AR (1) AR243889A1 (no)
AT (1) ATE62484T1 (no)
AU (1) AU582554B2 (no)
CA (1) CA1232605A (no)
DE (1) DE3484420D1 (no)
DK (1) DK165789C (no)
ES (2) ES8602786A1 (no)
FI (1) FI77034C (no)
GR (1) GR81006B (no)
HU (1) HU202528B (no)
IL (1) IL73586A (no)
NO (1) NO162019C (no)
PH (1) PH22068A (no)
SU (1) SU1512482A3 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO162019C (no) * 1983-11-23 1989-10-25 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoiskinolinderivater.
US4661592A (en) * 1984-06-27 1987-04-28 G. D. Searle & Co. 4H-pyrimido[2,1-a]isoquinolin-4-one derivatives
CA2711576C (en) 2008-01-25 2016-06-21 High Point Pharmaceuticals, Llc Tricyclic compounds as inhibitors of tnf-.alpha. synthesis and as pde4 inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876788A (en) * 1970-08-27 1975-04-08 Burroughs Wellcome Co Heterocyclic compounds in the treatment of inflammatory of arthritic conditions
US4017625A (en) * 1975-08-01 1977-04-12 Pfizer Inc. Anti-allergic N-(5-tetrazolyl)-1-oxo-1H-6-alkoxypyrimido-[1,2-a]quinoline-2-carboxamides and intermediates therefor
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom
US4127720A (en) * 1977-09-21 1978-11-28 Bristol-Myers Company Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity
IE51802B1 (en) * 1979-12-03 1987-04-01 Fujisawa Pharmaceutical Co Quinazoline derivatives,processes for their preparation and pharmaceutical compositions containing them
JPS59172490A (ja) * 1983-03-18 1984-09-29 Fujisawa Pharmaceut Co Ltd ピリミドイソキノリン誘導体およびその塩類、それらの製造法ならびにそれらを有効成分とする抗アレルギ−剤
JPS59172472A (ja) * 1983-03-18 1984-09-29 Fujisawa Pharmaceut Co Ltd イソキノリン誘導体およびその塩類、それらの製造法ならびにそれらを有効成分とする抗アレルギ−剤
NO162019C (no) * 1983-11-23 1989-10-25 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoiskinolinderivater.
US4661592A (en) * 1984-06-27 1987-04-28 G. D. Searle & Co. 4H-pyrimido[2,1-a]isoquinolin-4-one derivatives

Also Published As

Publication number Publication date
AU582554B2 (en) 1989-04-06
ES537928A0 (es) 1985-12-01
ES546222A0 (es) 1986-01-16
HU202528B (en) 1991-03-28
EP0143001B1 (en) 1991-04-10
FI77034B (fi) 1988-09-30
ATE62484T1 (de) 1991-04-15
DK536184A (da) 1985-05-24
FI844406L (fi) 1985-05-24
HUT35674A (en) 1985-07-29
NO162019C (no) 1989-10-25
NO162019B (no) 1989-07-17
DK536184D0 (da) 1984-11-09
KR850003538A (ko) 1985-06-20
PH22068A (en) 1988-05-20
KR920008168B1 (ko) 1992-09-24
IL73586A (en) 1988-12-30
FI844406A0 (fi) 1984-11-09
ES8604220A1 (es) 1986-01-16
AU3540584A (en) 1985-05-30
SU1512482A3 (ru) 1989-09-30
EP0143001A3 (en) 1986-03-19
EP0143001A2 (en) 1985-05-29
FI77034C (fi) 1989-01-10
KR920001673B1 (ko) 1992-02-22
DE3484420D1 (en) 1991-05-16
US4673676A (en) 1987-06-16
DK165789C (da) 1993-06-14
ES8602786A1 (es) 1985-12-01
DK165789B (da) 1993-01-18
AR243889A1 (es) 1993-09-30
CA1232605A (en) 1988-02-09
IL73586A0 (en) 1985-02-28
GR81006B (en) 1985-01-03

Similar Documents

Publication Publication Date Title
NO850300L (no) Fremgangsmaate for fremstilling av 3-imidazolylmetyl-tetrahydrokarbazolon-derivater
ES535978A0 (es) Procedimiento para preparar derivados de tiazol
NO164242C (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater.
ES536138A0 (es) Procedimiento para preparar derivados azolicos
NO813442L (no) Fremgangsmaate for fremstilling av 2-guanidin-4-heteroaryltiazolderivater
ES539255A0 (es) Procedimiento para preparar derivados de isoquinoleina
ES547467A0 (es) Procedimiento de preparacion de derivados aminometilfosfoni-cos
NO841657L (no) Fremgangsmaate for fremstilling av ergolinderivater.
ES536780A0 (es) Procedimiento de preparar nuevas bencensulfonil-lactamas
MX157033A (es) Procedimiento para preparar derivados de pirrolo quinoleina
NO820980L (no) Fremgangsmaate for fremstilling av imidazo-pyrimidin-derivater
ES534377A0 (es) Procedimiento para preparar derivados de antraciclina
MX7403E (es) Procedimiento para preparar derivados de benzoil-ureas
ES536964A0 (es) Procedimiento de preparar derivados de penicilina
NO841965L (no) Fremgangsmaate for fremstilling av 1,8-dihydroksy-10-acyl-9-antron-derivater
NO844090L (no) Fremgangsmaate for fremstilling av 2-azacykloalkyltio-2-penem-3-karboksylsyre-derivater
NO851550L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO845016L (no) Fremgangsmaate ved fremstilling av substituerte spiropyridinderivater
ES530626A0 (es) Procedimiento para preparar derivados de ciano-2-imidazopiridina
NO844466L (no) Fremgangsmaate for fremstilling av pyrimidoisokinolin-derivater
NO170928C (no) Fremgangsmaate for fremstilling av pyrimidintrionderivater
NO841485L (no) Fremgangsmaate for fremstilling av substituerte difenylazometinderivater
NO810461L (no) Fremgansmaate for fremstilling av benzyliden-derivater
ES532142A0 (es) Procedimiento para preparar derivados acilaminofenolicos
NO844943L (no) Fremgangsmaate for fremstilling av pyrrolo-indolderivater